India · Delayed Price · Currency is INR Pharmaids Pharmaceuticals Statistics
Total Valuation
BOM:524572 has a market cap or net worth of INR 1.14 billion. The enterprise value is 1.37 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.37B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:524572 has 35.27 million shares outstanding. The number of shares has increased by 0.37% in one year.
| Current Share Class | 35.27M |
| Shares Outstanding | 35.27M |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 67.95% |
| Owned by Institutions (%) | n/a |
| Float | 7.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.08 |
| PB Ratio | 2.39 |
| P/TBV Ratio | 7.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 0.49.
| Current Ratio | 0.46 |
| Quick Ratio | 0.15 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.74 |
| Interest Coverage | -4.46 |
Financial Efficiency
Return on equity (ROE) is -22.55% and return on invested capital (ROIC) is -21.91%.
| Return on Equity (ROE) | -22.55% |
| Return on Assets (ROA) | -9.39% |
| Return on Invested Capital (ROIC) | -21.91% |
| Return on Capital Employed (ROCE) | -24.61% |
| Weighted Average Cost of Capital (WACC) | 5.46% |
| Revenue Per Employee | 9.96M |
| Profits Per Employee | -4.18M |
| Employee Count | 28 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.72 |
Taxes
| Income Tax | -47.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.75% in the last 52 weeks. The beta is -0.02, so BOM:524572's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -44.75% |
| 50-Day Moving Average | 29.63 |
| 200-Day Moving Average | 42.22 |
| Relative Strength Index (RSI) | 63.20 |
| Average Volume (20 Days) | 22,531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524572 had revenue of INR 278.82 million and -117.17 million in losses. Loss per share was -3.31.
| Revenue | 278.82M |
| Gross Profit | 107.30M |
| Operating Income | -155.65M |
| Pretax Income | -163.03M |
| Net Income | -117.17M |
| EBITDA | -135.38M |
| EBIT | -155.65M |
| Loss Per Share | -3.31 |
Balance Sheet
The company has 1.34 million in cash and 233.82 million in debt, with a net cash position of -232.49 million or -6.59 per share.
| Cash & Cash Equivalents | 1.34M |
| Total Debt | 233.82M |
| Net Cash | -232.49M |
| Net Cash Per Share | -6.59 |
| Equity (Book Value) | 476.03M |
| Book Value Per Share | 13.43 |
| Working Capital | -130.18M |
Cash Flow
In the last 12 months, operating cash flow was -40.57 million and capital expenditures -44.72 million, giving a free cash flow of -85.29 million.
| Operating Cash Flow | -40.57M |
| Capital Expenditures | -44.72M |
| Depreciation & Amortization | 20.27M |
| Net Borrowing | -185.33M |
| Free Cash Flow | -85.29M |
| FCF Per Share | -2.42 |
Margins
Gross margin is 38.48%, with operating and profit margins of -55.82% and -42.02%.
| Gross Margin | 38.48% |
| Operating Margin | -55.82% |
| Pretax Margin | -58.47% |
| Profit Margin | -42.02% |
| EBITDA Margin | -48.55% |
| EBIT Margin | -55.82% |
| FCF Margin | n/a |
Dividends & Yields
BOM:524572 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.37% |
| Earnings Yield | -10.29% |
| FCF Yield | -7.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |